Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy.

MLA

Surial, Bernard, et al. “Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 77, no. 5, Sept. 2023, pp. 729–37. EBSCOhost, https://doi.org/10.1093/cid/ciad286.

APA

Surial, B., Chammartin, F., Damas, J., Calmy, A., Haerry, D., Stöckle, M., Schmid, P., Bernasconi, E., Fux, C. A., Tarr, P. E., Günthard, H. F., Wandeler, G., & Rauch, A. (2023). Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 77(5), 729–737. https://doi.org/10.1093/cid/ciad286

Chicago

Surial, Bernard, Frédérique Chammartin, José Damas, Alexandra Calmy, David Haerry, Marcel Stöckle, Patrick Schmid, et al. 2023. “Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 77 (5): 729–37. doi:10.1093/cid/ciad286.